Some interesting points on Jublia...
Jublia retails at about $1,000 for an 8-milliliter bottle, while a 4-milliliter bottle costs more than $500.
The drug has three different patents, out of which one is set to expire in 2021, and two in 2030.
Valeant quarterly reports show Jublia pulled in $270 million in revenue in the first three quarters of 2015
Valeant was originally guiding for U.S. Jublia sales to peak between $300 and $800
Valeant spent [wasted] $4.5M on a Super Bowl toe-fungus ad
- Forums
- ASX - By Stock
- ACR
- Ann: IPR Petition Filed Against Key Jublia Patent-ACR.AX
Ann: IPR Petition Filed Against Key Jublia Patent-ACR.AX, page-2
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.6¢ |
Change
-0.001(1.75%) |
Mkt cap ! $16.28M |
Open | High | Low | Value | Volume |
5.9¢ | 5.9¢ | 5.5¢ | $6.243K | 110.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 46219 | 5.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 15000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 46219 | 0.055 |
1 | 18800 | 0.053 |
1 | 150000 | 0.052 |
5 | 795490 | 0.050 |
1 | 88000 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 185000 | 2 |
0.059 | 225945 | 1 |
0.060 | 423988 | 3 |
0.061 | 100000 | 1 |
0.062 | 116100 | 2 |
Last trade - 11.10am 09/09/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |